Cerebroprotein hydrolysate belongs to the therapeutic class of neurotrophic agents.

Cerebroprotein hydrolysate is used in managing neurodegenerative disorders such as Alzheimer's and Parkinson's diseases and for supporting cognitive function in cases of age-related cognitive decline. Additionally, it is believed to have neuroprotective properties and shows promise in experimental therapeutic approaches for certain neurological conditions.

Cerebroprotein hydrolysate can be administered through various routes, including oral ingestion, intramuscular injection, and intravenous infusion. The specific route of administration may depend on the formulation, dosage, and the condition being treated. 

Cerebroprotein hydrolysate may lead to gastrointestinal discomfort, allergic reactions like skin rash or itching, and, in rare cases, severe allergic reactions such as anaphylaxis. Neurological effects may occur, including the worsening of existing conditions or the development of new symptoms.

Some individuals may be allergic to components of Cerebroprotein hydrolysate, leading to allergic reactions ranging from mild symptoms such as skin rash to severe reactions like anaphylaxis. Individuals may sometimes experience neurological effects, such as worsening existing neurological conditions or developing new neurological symptoms. Gastrointestinal discomfort, including nausea, vomiting, or stomach upset, may occur in some individuals.

Before starting Cerebroprotein hydrolysate, individuals should be evaluated for any history of allergies or hypersensitivity reactions. Any signs of an allergic reaction, such as rash, itching, difficulty breathing, or gastrointestinal discomfort, should be immediately reported to a healthcare professional. Any unusual neurological effects should be promptly discussed with a healthcare provider.

Be cautious if you have known allergies or pre-existing medical conditions, particularly concerning the liver, kidneys, or immune system, before taking Cerebroprotein hydrolysate. Avoid using it during pregnancy and breastfeeding unless specifically recommended by a healthcare professional. Use it carefully in children, and be aware of potential interactions with other medications. Regular monitoring and follow-ups are necessary to assess its effectiveness and watch for any adverse effects or changes in your condition. Use it cautiously if you have autoimmune disorders, ongoing infections, or are immunocompromised. Adjust the dosage if you have kidney problems, and follow the prescribed treatment plan without exceeding the recommended duration of use. Monitor for any adverse reactions and consult a healthcare provider with concerns.

1. Zehui Liu et al.; CH(II), a cerebroprotein hydrolysate, exhibits potential neuroprotective effect on Alzheimer's disease; PLoS One; [Published on 23rd Sept 2019] [Accessed on 17th Oct 2023]; http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6756745/

The drug information on this page is not a substitute for medical advice, it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.